Bridgewater Advisors Inc. Purchases 4,995 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Bridgewater Advisors Inc. lifted its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 6.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,352 shares of the construction company’s stock after acquiring an additional 4,995 shares during the quarter. Bridgewater Advisors Inc. owned 0.10% of Aspen Aerogels worth $1,027,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of ASPN. Franklin Resources Inc. boosted its holdings in shares of Aspen Aerogels by 5.3% in the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock worth $815,000 after buying an additional 1,483 shares during the last quarter. nVerses Capital LLC boosted its stake in Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after acquiring an additional 1,800 shares during the last quarter. Point72 Hong Kong Ltd bought a new position in shares of Aspen Aerogels during the 2nd quarter valued at approximately $84,000. Quent Capital LLC purchased a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $118,000. Finally, Point72 DIFC Ltd bought a new stake in shares of Aspen Aerogels in the 2nd quarter worth approximately $121,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Roth Mkm dropped their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Barclays reduced their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Piper Sandler reduced their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.11.

Aspen Aerogels Trading Up 1.3 %

Shares of ASPN stock opened at $12.73 on Monday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The business has a 50-day moving average of $13.47 and a 200 day moving average of $20.18. The stock has a market capitalization of $1.04 billion, a PE ratio of 1,273.77 and a beta of 2.14. Aspen Aerogels, Inc. has a 1-year low of $10.75 and a 1-year high of $33.15.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.